{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:39:18Z","timestamp":1762522758644,"version":"3.41.2"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T00:00:00Z","timestamp":1664323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Group B <jats:italic>Streptococcus<\/jats:italic> (GBS) infection in infants may result in both respiratory, cardiovascular, and neurological dysfunction and ultimately death of the infant. Surveillance of GBS strains in infants and their clinical characteristics guide development of effective vaccines and other potential treatments and may have implications for future prognostics and infant care. Therefore, we aimed to study GBS serotypes and clonal complexes (CC) in Danish infants with early onset infection (EOD) (0\u20136 days of life) and late-onset infection (LOD) (7\u201389 days of life) and to estimate the association between GBS strain and different clinical outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We included Danish infants less than 3 months of age with GBS isolates from blood or cerebrospinal fluid between 1999 and 2009. GBS isolates were analyzed by serotyping and multilocus sequence typing with classification of isolates into clonal complexes. Clinical characteristics were obtained by questionnaires completed by tending pediatrician including gestational age, Apgar scores, age at onset, meningitis, symptom severity, treatment duration, and mortality. Symptom severities were reported within neurological symptoms, need for respiratory or circulatory support, and treatment of disseminated intravascular coagulation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 212 GBS isolates were collected with 129 from EOD and 83 from LOD. The dominating GBS strains were III\/CC17 (41%), Ia\/CC23 (17%), III\/CC19 (15%), Ib\/CC8-10 (7%), and V\/CC1 (6%). Strain Ia\/CC23 was mostly found in EOD, while III\/CC17 was widespread in LOD, though being the most common in both EOD and LOD. Strain III\/CC17 and Ia\/CC23 had highest percentage of samples from cerebrospinal fluid (26%), while III\/CC19 had the least (8%). Strain III\/CC19 had highest mortality with about one fifth of infected infants dying (22%) followed by Ia\/CC23 (16%), Ib\/CC8-10 (9%), and then III\/CC17 (6%). The symptom severity varied between strains, but with no strain consistently resulting in more severe symptoms.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Some potential differences in disease severity were observed between the different strains. These findings emphasize the continuous need for multimodal surveillance of infant GBS strains and their clinical characteristics to optimize development of GBS vaccines and other potential treatments.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmicb.2022.1001953","type":"journal-article","created":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T06:49:23Z","timestamp":1664347763000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Invasive group B Streptococcus strains and clinical characteristics in Danish infants from 1999 to 2009"],"prefix":"10.3389","volume":"13","author":[{"given":"Mads","family":"Andersen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgitte","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"May","family":"Murra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stine Yde","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-Christian","family":"Slotved","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tine Brink","family":"Henriksen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,28]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"001426","DOI":"10.1099\/jmm.0.001426","article-title":"Group B streptococcal infections in infants in Iceland: Clinical and microbiological factors.","volume":"70","author":"Baeringsdottir","year":"2021","journal-title":"J. Med. Microbiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/S1473-3099(14)70919-3","article-title":"Incidence of invasive group B streptococcal disease and pathogen genotype distribution in newborn babies in the Netherlands over 25 years: A nationwide surveillance study.","volume":"14","author":"Bekker","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1093\/infdis\/jis605","article-title":"Capsular switching in group B Streptococcus CC17 hypervirulent clone: A future challenge for polysaccharide vaccine development.","volume":"206","author":"Bellais","year":"2012","journal-title":"J. Infect. Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"6682","DOI":"10.1016\/j.vaccine.2020.08.052","article-title":"Systematic review of Group B Streptococcal capsular types, sequence types and surface proteins as potential vaccine candidates.","volume":"38","author":"Bianchi-Jassir","year":"2020","journal-title":"Vaccine"},{"key":"B5","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1093\/infdis\/jiz062","article-title":"A Novel Hexavalent Capsular Polysaccharide Conjugate Vaccine (GBS6) for the Prevention of Neonatal Group B Streptococcal Infections by Maternal Immunization.","volume":"220","author":"Buurman","year":"2019","journal-title":"J. Infect. Dis."},{"key":"B6","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.2147\/IDR.S203454","article-title":"Vaccine Against Group B Streptococcus: Recent Advances.","volume":"13","author":"Carreras-Abad","year":"2020","journal-title":"Infect. Drug Resist."},{"key":"B7","doi-asserted-by":"publisher","first-page":"e136737","DOI":"10.1172\/JCI136737","article-title":"CC17 group B Streptococcus exploits integrins for neonatal meningitis development.","volume":"131","author":"Deshayes de Cambronne","year":"2021","journal-title":"J. Clin. Investig."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1017\/s0950268804002808","article-title":"Invasive group B streptococcal disease in infants: A 19-year nationwide study. Serotype distribution, incidence and recurrent infection.","volume":"132","author":"Ekelund","year":"2004","journal-title":"Epidemiol. Infect."},{"key":"B9","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1111\/j.1469-0691.2005.01169.x","article-title":"Invasive group A. B, C and G streptococcal infections in Denmark 1999-2002: Epidemiological and clinical aspects.","volume":"11","author":"Ekelund","year":"2005","journal-title":"Clin. Microbiol. Infect."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e0222910","DOI":"10.1371\/journal.pone.0222910","article-title":"Genetically distinct Group B Streptococcus strains induce varying macrophage cytokine responses.","volume":"14","author":"Flaherty","year":"2019","journal-title":"PloS one."},{"key":"B11","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/1471-0528.16085","article-title":"Universal screening versus risk-based protocols for antibiotic prophylaxis during childbirth to prevent early-onset group B streptococcal disease: A systematic review and meta-analysis.","volume":"127","author":"Hasperhoven","year":"2020","journal-title":"BJOG"},{"key":"B12","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/S2352-4642(21)00022-5","article-title":"Mortality, neurodevelopmental impairments, and economic outcomes after invasive group B streptococcal disease in early infancy in Denmark and the Netherlands: A national matched cohort study.","volume":"5","author":"Horvath-Puho","year":"2021","journal-title":"Lancet Child. Adolesc. Health"},{"key":"B13","doi-asserted-by":"publisher","first-page":"9539","DOI":"10.1038\/s41598-020-66214-3","article-title":"Increasing incidence of group B streptococcus neonatal infections in the Netherlands is associated with clonal expansion of CC17 and CC23.","volume":"10","author":"Jamrozy","year":"2020","journal-title":"Sci. Rep."},{"key":"B14","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1128\/JCM.41.6.2530-2536.2003","article-title":"Multilocus sequence typing system for group B streptococcus.","volume":"41","author":"Jones","year":"2003","journal-title":"J. Clin. Microbiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1086\/500324","article-title":"Enhanced invasiveness of bovine-derived neonatal sequence type 17 group B streptococcus is independent of capsular serotype.","volume":"42","author":"Jones","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1186\/s12879-019-4177-y","article-title":"Emerging serotype III sequence type 17 group B streptococcus invasive infection in infants: The clinical characteristics and impacts on outcomes.","volume":"19","author":"Kao","year":"2019","journal-title":"BMC Infect. Dis."},{"key":"B17","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ejogrb.2017.06.019","article-title":"Risk-based screening combined with a PCR-based test for group B streptococci diminishes the use of antibiotics in laboring women.","volume":"215","author":"Khalil","year":"2017","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/ijgo.12721","article-title":"Risk-based approach versus culture-based screening for identification of group B streptococci among women in labor.","volume":"144","author":"Khalil","year":"2019","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"B19","doi-asserted-by":"publisher","first-page":"000783","DOI":"10.1099\/mgen.0.000783","article-title":"Identifying large-scale recombination and capsular switching events in Streptococcus agalactiae strains causing disease in adults in the UK between 2014 and 2015.","volume":"8","author":"Khan","year":"2022","journal-title":"Microb. Genom."},{"key":"B20","doi-asserted-by":"publisher","first-page":"S190","DOI":"10.1093\/cid\/cix663","article-title":"Neurodevelopmental Impairment in Children After Group B Streptococcal Disease Worldwide: Systematic Review and Meta-analyses.","volume":"65","author":"Kohli-Lynch","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3109\/00365540903501616","article-title":"Molecular characterization of invasive penicillin non-susceptible Streptococcus pneumoniae from Denmark, 2001 to 2005.","volume":"42","author":"Lambertsen","year":"","journal-title":"Scand. J. Infect. Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1007\/s10096-010-0941-z","article-title":"Characterisation of invasive group B streptococci from adults in Denmark 1999 to 2004.","volume":"29","author":"Lambertsen","year":"","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"O216","DOI":"10.1111\/1469-0691.12378","article-title":"Nationwide laboratory-based surveillance of invasive beta-haemolytic streptococci in Denmark from 2005 to 2011.","volume":"20","author":"Lambertsen","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"B24","doi-asserted-by":"publisher","first-page":"14322","DOI":"10.1038\/s41598-018-32774-8","article-title":"The plasminogen binding protein PbsP is required for brain invasion by hypervirulent CC17 Group B streptococci.","volume":"8","author":"Lentini","year":"2018","journal-title":"Sci. Rep."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1067\/mob.2001.113875","article-title":"The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal group B streptococcal disease.","volume":"184","author":"Lin","year":"2001","journal-title":"Am. J. Obstet. Gynecol."},{"key":"B26","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jmii.2017.09.002","article-title":"Serotype distribution and clinical correlation of Streptococcus agalactiae causing invasive disease in infants and children in Taiwan.","volume":"52","author":"Lo","year":"2019","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1093\/cid\/cix666","article-title":"Antibody Kinetics and Response to Routine Vaccinations in Infants Born to Women Who Received an Investigational Trivalent Group B Streptococcus Polysaccharide CRM197-Conjugate Vaccine During Pregnancy.","volume":"65","author":"Madhi","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"B28","doi-asserted-by":"crossref","first-page":"S160","DOI":"10.1093\/cid\/cix656","article-title":"Infant Group B Streptococcal Disease Incidence and Serotypes Worldwide: Systematic Review and Meta-analyses.","volume":"65","author":"Madrid","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1128\/JCM.01424-08","article-title":"Multilocus sequence types associated with neonatal group B streptococcal sepsis and meningitis in Canada.","volume":"47","author":"Manning","year":"2009","journal-title":"J. Clin. Microbiol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.1128\/JCM.01182-07","article-title":"Analysis of group B streptococcal isolates from infants and pregnant women in Portugal revealing two lineages with enhanced invasiveness.","volume":"45","author":"Martins","year":"2007","journal-title":"J. Clin. Microbiol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"574.e7","DOI":"10.1016\/j.cmi.2017.02.021","article-title":"Short-read whole genome sequencing for determination of antimicrobial resistance mechanisms and capsular serotypes of current invasive Streptococcus agalactiae recovered in the USA.","volume":"23","author":"Metcalf","year":"2017","journal-title":"Clin. Microbiol. Infect."},{"key":"B32","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1001\/jama.298.12.1390","article-title":"Streptococcal Disease After Universal Screening Recommendations\u2014United States, 2003-2005.","volume":"298","author":"Perinatal Group","year":"2007","journal-title":"JAMA"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.3201\/eid2611.201669","article-title":"Multidrug-Resistant Hypervirulent Group B Streptococcus in Neonatal Invasive Infections. France, 2007-2019.","volume":"26","author":"Plainvert","year":"2020","journal-title":"Emerg. Infect. Dis."},{"key":"B34","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.3201\/eid1410.080185","article-title":"Invasive group B streptococcal infections in infants. France.","volume":"14","author":"Poyart","year":"2008","journal-title":"Emerg. Infect. Dis."},{"key":"B35","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1093\/cid\/cix658","article-title":"Maternal Colonization With Group B Streptococcus and Serotype Distribution Worldwide: Systematic Review and Meta-analyses.","volume":"65","author":"Russell","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"B36","doi-asserted-by":"publisher","first-page":"S200","DOI":"10.1093\/cid\/cix664","article-title":"Estimates of the Burden of Group B Streptococcal Disease Worldwide for Pregnant Women, Stillbirths, and Children.","volume":"65","author":"Seale","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"B37","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3389\/fmicb.2018.00437","article-title":"Group B Streptococcal Colonization, Molecular Characteristics, and Epidemiology.","volume":"9","author":"Shabayek","year":"2018","journal-title":"Front. Microbiol."},{"key":"B38","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1128\/JCM.41.9.4445-4447.2003","article-title":"Latex assay for serotyping of group B Streptococcus isolates.","volume":"41","author":"Slotved","year":"2003","journal-title":"J. Clin. Microbiol."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2020.00040","article-title":"The Epidemiology of Invasive Group B Streptococcus in Denmark From 2005 to 2018.","volume":"40","author":"Slotved","year":"2020","journal-title":"Front. Public Health"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1128\/JCM.40.5.1882-1883.2002","article-title":"False-negative results in typing of group B streptococci by the standard lancefield antigen extraction method.","volume":"40","author":"Slotved","year":"2002","journal-title":"J. Clin. Microbiol."},{"journal-title":"Seneste opdateringer","year":"1850","key":"B41"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1084\/jem.20092594","article-title":"The surface protein HvgA mediates group B streptococcus hypervirulence and meningeal tropism in neonates.","volume":"207","author":"Tazi","year":"2010","journal-title":"J. Exp. Med."},{"journal-title":"Urgent need for vaccine to prevent deadly Group B streptococcus.","year":"2021","key":"B43"},{"key":"B44","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12887-020-02048-2","article-title":"Etiological serotype and genotype distributions and clinical characteristics of group B streptococcus-inducing invasive disease among infants in South China.","volume":"20","author":"Zhu","year":"2020","journal-title":"BMC Pediatr."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2022.1001953\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T06:49:32Z","timestamp":1664347772000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2022.1001953\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,28]]},"references-count":44,"alternative-id":["10.3389\/fmicb.2022.1001953"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2022.1001953","relation":{},"ISSN":["1664-302X"],"issn-type":[{"type":"electronic","value":"1664-302X"}],"subject":[],"published":{"date-parts":[[2022,9,28]]},"article-number":"1001953"}}